Cargando…
Ways Out of the Patenting Prohibition? Human Parthenogenetic and Induced Pluripotent Stem Cells
According to the judgement of the European Court of Justice in 2014, human parthenogenetic stem cells are excluded from the patenting prohibition of procedures based on hESC by the European Biopatent Directive, because human parthenotes are not human embryos. This article is based on the thesis that...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484380/ https://www.ncbi.nlm.nih.gov/pubmed/28182296 http://dx.doi.org/10.1111/bioe.12334 |